Effect of Breviscapin on the Efflux Activity of P-gp in Caco-2 Cells
(1. College of Pharmacy and Chemistry, Dali University, Dali, Yunnan 671000, China; 2. Key Laboratory of Pharmaceutical R & D of
Insects in Yunnan Province, Dali, Yunnan 671000, China)
Zhou Xuan, Cao Chang'e, Yang Jiao, Yang Meisong, Shao Mingyuan, Gao Yangyang, La. Effect of Breviscapin on the Efflux Activity of P-gp in Caco-2 Cells[J]. , 2017, 2(4): 20-23.
〔1〕JIANG N H,ZHANG G H,ZHANG J J,et al. Analysis of
the transcriptome of Erigeron breviscapus uncovers puta?
tive scutellarin and chlorogenic acids biosynthetic genes
and genetic markers〔J〕. PLoS ONE,2014,9(6):100357.
〔2〕孙文基,绳金房. 天然活性成分简明手册〔M〕. 北京:中
国医药科技出版社,1998.
〔3〕XU Q Y,LI X X. Influences of deng zhan xi xin injection
on blood viscosity in patients with high blood viscosity〔J〕.
Chin New Drugs Clin Rew,1995,14(4):233-235.
〔4〕ZHANG H F,HU X M,WANG L X,et al. Protective effects
of scutellarin against cerebral ischemia in rats:evidence for
inhibition of the apoptosis- inducing factor pathway〔J〕.
Planta Med,2009,75(2):121-126.
〔5〕ZHANG L,REYNOLDS K S,ZHAO P,et al. Drug interac?
tions evaluation:an integrated part of risk assessment of
therapeutics〔J〕. Toxicol Appl Pharmacol,2010,243(2):
134-145.
〔6〕JONES P M,GEORGE A M. Opening of the ADP-bound
active site in the ABC transporter ATPase dimer:evidence
for a constant contact,alternating sites model for the cata?
lytic cycle〔J〕. Proteins,2009,75(2):387-396.
〔7〕KUMAR Y S,ADUKONDALU D,SATHISH D,et al. PGlycoprotein
and cytochrome P-450-mediated herbal drug
interactions〔J〕. Drug Metabol Drug Interact,2010,25(1):
3-16.
〔8〕MARCHETTI S,MAZZANTI R,BEIJNEN J H,et al. Con?
cise review:Clinical relevance of drug drug and herb drug
interactions mediated by the ABC transporter ABCB1
(MDR1,P- glycoprotein)〔J〕. Oncologist,2007,12(8):
927-941.
〔9〕CHEN X,JIN J,CHEN Y,et al. Effect of scutellarin on the
metabolism and pharmacokinetics of clopidogrel in rats〔J〕.
Biopharm Drug Dispos,2015,36(1):64-68.
〔10〕YOU H S,ZHANG H F,DONG Y L,et al. Absorption and
transportation characteristics of scutellarin and scutella?
rein across Caco-2 monolayer model〔J〕. Journal of Chi?
nese integrative medicine,2010,8(9):863-869.
〔11〕金桂兰,覃慧林,石孟琼,等. 灯盏花素对小鼠局灶性脑
缺血损伤的保护作用及与脑组织P-糖蛋白表达研
究〔J〕. 中药药理与临床,2015,31(1):76-79.
〔12〕HAN Y L,LI D,YANG Q J,et al. In vitro inhibitory ef?
fects of scutellarin on six human/rat cytochrome P450 en?
zymes and P-glycoprotein〔J〕. Molecules,2014,19(5):
5748-5760.
〔13〕VARMA M V,ASHOKRAJ Y,DEY C S,et al. P-glyco?
protein inhibitors and their screening:a perspective from
bioavailability enhancement〔J〕. Pharmacol Res,2003,48
(4):347-359.
〔14〕朱宝英,黄静,王永林,等. P-糖蛋白及肿瘤多药耐药的
逆转〔J〕. 中国药房,2011,22(6):550-552.